Get the Stockscreener App
1.31
2.34%
0.03
Pre-market:
1.31
Akanda Corp stock is traded at $1.31, with a volume of 7,952.
It is up +2.34% in the last 24 hours and up +9.17% over the past month.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.
See More
Previous Close:
$1.28
Open:
$1.28
24h Volume:
7,952
Relative Volume:
0.26
Market Cap:
$3.23M
Revenue:
$2.51M
Net Income/Loss:
$-29.08M
P/E Ratio:
-0.00284
EPS:
-461.78
Net Cash Flow:
$-4.52M
1W Performance:
-7.75%
1M Performance:
+9.17%
6M Performance:
-4.38%
1Y Performance:
-71.15%
1-Day Range:
$1.28
$1.32
1-Week Range:
$1.25
$1.4627
52-Week Range:
$0.9301
$5.76
Akanda Corp Stock (AKAN) Company Profile
Compare AKAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AKAN
Akanda Corp
|
1.31 | 3.23M | 2.51M | -29.08M | -4.52M | -461.78 |
|
RGC
Regencell Bioscience Holdings Ltd
|
78.00 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
161.67 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.50 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.89 | 47.60B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Akanda Corp Stock (AKAN) Latest News
Coloured Ties Capital Inc. Announces Private Placement for Gross Proceeds of up to $750,000 | APEOF Stock News - GuruFocus
Coloured Ties Capital Inc. Announces Private Placement for Gross Proceeds of up to $750,000 - The Globe and Mail
Akanda Corp. (NASDAQ:AKAN) Short Interest Down 15.1% in May - Defense World
Akanda (NASDAQ:AKAN) Shares Up 3.3% – Still a Buy? - Defense World
Akanda Corp. Shareholders Approve Key Proposals at April 2025 Meeting - TipRanks
Akanda Corp. Appoints Usama Chaudhry as Independent Director - MSN
Akanda Corp. Announces April 2025 Shareholder Meeting with Key Governance Decisions - TipRanks
Akanda stock hits 52-week low at $1.22 amid sharp annual decline - Investing.com India
Akanda stock hits 52-week low at $1.22 amid sharp annual decline By Investing.com - Investing.com South Africa
Akanda Corp. Engages in Private Offering and Amends Share Exchange Agreement - TipRanks
Akanda (NASDAQ:AKAN) Trading Up 2.6% – Should You Buy? - Defense World
Akanda Corp.’s Chief Executive Officer Submits Resignation - Business Wire
Akanda Sells UK's Canmart as it Pivots Away From Cannabis, Argent Bio Seeks Deals for Malta Facility, & Chill Brands to Raise £1m - Business of Cannabis
Akanda Corp. Announces Strategic Shift with Acquisition and Operational Changes - TipRanks
Akanda to acquire First Towers, shifts focus from UK to Latin America By Investing.com - Investing.com South Africa
Akanda to acquire First Towers, shifts focus from UK to Latin America - Investing.com
Akanda Corp. Announces Share Exchange Agreement with First Towers and Fiber Corp - Newsfile
Short Interest in Akanda Corp. (NASDAQ:AKAN) Rises By 121.5% - Defense World
Akanda announces subsequent registered direct offering - MSN
Akanda (NASDAQ:AKAN) Stock Quotes, Forecast and News Summary - Benzinga
Akanda Corp (AKAN) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Examining AKAN’s book value per share for the latest quarter - US Post News
Akanda Corp. (NASDAQ:AKAN) Sees Significant Drop in Short Interest - Defense World
Certain Pre -Funded Warrants of Akanda Corp. are subject to a Lock-Up Agreement Ending on 1-JAN-2025. - Marketscreener.com
Akanda Corp. (NASDAQ:AKAN) Sees Significant Decline in Short Interest - Defense World
Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding - Business of Cannabis
Akanda Corp. Announces Reverse Stock Split - Newsfile
Akanda stock plunges to 52-week low of $0.66 amid market challenges - Investing.com
Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma - Business of Cannabis
Akanda Corp. Shows Financial Growth Amid Challenges - TipRanks
Akanda stock hits 52-week low at $0.91 amid steep annual decline - Investing.com
Akanda stock plunges to 52-week low of $1 amid market challenges - Investing.com India
Akanda Corp. Announces Closing of Underwritten Public Offering - Yahoo Finance
Akanda Corp. Announces Pricing of Underwritten Public Offering - Newsfile
Akanda Corp. Secures Hemp Cultivation License in Canada, Building on Previous Development Agreement - Yahoo Finance
Akanda Corporation Announces Completion of F-3 Shelf Registration Statement - Yahoo Finance
3 Penny Stocks to Watch Now - TipRanks
What's Going On With Medical Cannabis Company Akanda Stock Friday? - Benzinga
Akanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon - Business of Cannabis
Akanda Announces Stock Consolidation - Yahoo Finance
Akanda Announces Closing of Subsequent Registered Direct Offering - Yahoo Finance
Akanda Corp. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Akanda Corp. Receives Notice of Non-Compliance from NASDAQ - Yahoo Finance
Akanda Corp Announces Settlement Agreement with Former CEO Tejinder Virk - Newsfile
Akanda Corp. Announces Plans to Be Among International First Movers Pending Completion of Landmark Change in US Drug Policy - Yahoo Finance
Akanda Appoints Cooper to the Board of Directors - Newsfile
Akanda halts equity financing to explore strategic investments By Investing.com - Investing.com Canada
Akanda Looks to Commercialize and Capitalize on Germany's Legalization of Cannabis, Opening Path to $3BN Market - Investing.com India
Akanda Corp. Announces Closing of the Sale of RPK - Yahoo Finance
Akanda strengthens team to scale European medical cannabis access - Business of Cannabis
IMC Stock Jumps Over 60%, Akanda Announces New Strategic Plan, & MGC Becomes Argent BioPharma - Business of Cannabis -
Akanda Corp Stock (AKAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):